Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2017 2
2018 1
2019 7
2020 11
2021 1
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts.
Younoussa A, Samidine SN, Bergeman AT, Piubello A, Attoumani N, Grillone SH, Braet SM, Tsoumanis A, Baco A, Mzembaba A, Salim Z, Amidy M, Grillone S, Snijders R, Corstjens P, Ortuno-Gutierrez N, Hoof C, Geluk A, de Jong BC, Hasker E. Younoussa A, et al. Among authors: piubello a. BMC Infect Dis. 2023 May 9;23(1):310. doi: 10.1186/s12879-023-08290-0. BMC Infect Dis. 2023. PMID: 37161571 Free PMC article. Clinical Trial.
High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin.
Souleymane MB, Kadri S, Piubello A, Tsoumanis A, Soumana A, Issa H, Amoussa AK, Van Deun A, Lynen L, de Jong BC, Decroo T. Souleymane MB, et al. Among authors: piubello a. Int J Infect Dis. 2023 Aug;133:78-81. doi: 10.1016/j.ijid.2023.05.002. Epub 2023 May 5. Int J Infect Dis. 2023. PMID: 37150352 Free article. Clinical Trial.
Safety, effectiveness, and adherence of a short and all-oral treatment regimen for the treatment of rifampicin-resistant tuberculosis in Niger: a study protocol of a pragmatic randomised clinical trial with stratified block randomisation.
Souleymane MB, Decroo T, Soumana A, Maman Lawan I, Gagara-Issoufou A, Halidou-Moussa S, Ortuño-Gutiérrez N, Adehossi E, Mamadou S, Van Deun A, Piubello A. Souleymane MB, et al. Among authors: piubello a. Trials. 2022 Dec 13;23(1):1011. doi: 10.1186/s13063-022-06912-7. Trials. 2022. PMID: 36514153 Free PMC article.
Programmatic management of rifampicin-resistant tuberculosis with standard regimen in Cameroon: a retrospective cohort study.
Jouego CG, Gils T, Piubello A, Mbassa V, Kuate A, Ngono A, Belinga E, Etoundi A, Tollo A, Makondi D, André E, Masumbe P, Lynen L, Noeske J, Decroo T. Jouego CG, et al. Among authors: piubello a. Int J Infect Dis. 2022 Nov;124:81-88. doi: 10.1016/j.ijid.2022.09.012. Epub 2022 Sep 13. Int J Infect Dis. 2022. PMID: 36108960 Free article.
Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort study.
Souleymane MB, Decroo T, Mamadou S, Soumana A, Lawan IM, Gagara-Issoufou A, Adehossi E, Ortuño-Gutiérrez N, Lynen L, Rigouts L, de Jong BC, Van Deun A, Piubello A. Souleymane MB, et al. Among authors: piubello a. Int Health. 2023 May 2;15(3):258-264. doi: 10.1093/inthealth/ihac016. Int Health. 2023. PMID: 35420123 Free PMC article.
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020.
Migliori GB, Thong PM, Akkerman O, Alffenaar JW, Álvarez-Navascués F, Assao-Neino MM, Bernard PV, Biala JS, Blanc FX, Bogorodskaya EM, Borisov S, Buonsenso D, Calnan M, Castellotti PF, Centis R, Chakaya JM, Cho JG, Codecasa LR, D'Ambrosio L, Denholm J, Enwerem M, Ferrarese M, Galvão T, García-Clemente M, García-García JM, Gualano G, Gullón-Blanco JA, Inwentarz S, Ippolito G, Kunst H, Maryandyshev A, Melazzini M, de Queiroz Mello FC, Muñoz-Torrico M, Njungfiyini PB, Palmero DJ, Palmieri F, Piccioni P, Piubello A, Rendon A, Sabriá J, Saporiti M, Scognamiglio P, Sharma S, Silva DR, Souleymane MB, Spanevello A, Tabernero E, Tadolini M, Tchangou ME, Thornton ABY, Tiberi S, Udwadia ZF, Sotgiu G, Ong CWM, Goletti D. Migliori GB, et al. Among authors: piubello a. Emerg Infect Dis. 2020 Nov;26(11):2709-2712. doi: 10.3201/eid2611.203163. Epub 2020 Sep 11. Emerg Infect Dis. 2020. PMID: 32917293 Free PMC article.
High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing loss.
Souleymane MB, Piubello A, Lawan IM, Hassane-Harouna S, Assao-Neino MM, Soumana A, Hamidou-Harouna Z, Gagara-Issoufou A, Ortuño-Gutiérrez N, Roggi A, Schwoebel V, Mamadou S, Lynen L, De Jong B, Van Deun A, Decroo T. Souleymane MB, et al. Among authors: piubello a. Eur Respir J. 2021 Jan 21;57(1):2002250. doi: 10.1183/13993003.02250-2020. Print 2021 Jan. Eur Respir J. 2021. PMID: 32703777 Free article.
The looming threat of bedaquiline resistance in tuberculosis.
Chiang CY, Trébucq A, Piubello A, Rieder HL, Schwoebel V, Van Deun A. Chiang CY, et al. Among authors: piubello a. Eur Respir J. 2020 Jun 4;55(6):2000718. doi: 10.1183/13993003.00718-2020. Print 2020 Jun. Eur Respir J. 2020. PMID: 32499309 Free article. No abstract available.
27 results